Vaccine
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) | HHS-NIH11 |
07/13/2020 |
07/07/2021 |
|
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) | NIH |
03/31/2020 |
07/28/2022 |
|
| Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) |
NIH |
03/09/2020 |
07/28/2020 |
|
| Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) |
NIH |
03/06/2020 |
07/28/2020 |
|
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
NIH |
12/09/2019 |
09/07/2022 |
|
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
NIH |
11/22/2019 |
01/07/2023 |
|
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
NIH |
08/29/2019 |
09/07/2022 |
|
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) |
NIH |
08/29/2019 |
07/16/2022 |
|
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
NIH |
08/29/2019 |
09/07/2022 |
|
| Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) |
NIH |
06/28/2019 |
01/14/2022 |
|
|
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed) |
NIH |
04/11/2019 |
06/18/2021 |
|
|
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed) |
NIH |
04/11/2019 |
06/10/2021 |
|
|
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed) |
NIH |
11/26/2018 |
01/07/2022 |
|
|
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) |
NIH |
11/13/2018 |
01/07/2022 |
|
|
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
NIH |
11/13/2018 |
01/07/2022 |
|
|
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) |
NIH |
7/24/2018 |
9/7/2021 |
|
|
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) |
NIH |
7/24/2018 |
9/7/2021 |
|
|
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) |
NIH |
7/18/2018 |
9/7/2021 |
|
|
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) |
NIH |
7/18/2018 |
9/7/2021 |
|
|
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed) |
NIH |
5/11/2018 |
9/9/2020 |